Back to Agenda
Session 9: Regulator Panel – Regional and Global Updates Part 2
Session Chair(s)
Renata De Lima Soares
Regulation and Health Surveillance Specialist, Anvisa, Brazil
Carla Chávez
Coordinadora de Seguridad y Eficacia, DIGEMID, Peru
This session is intended for each National Regulatory Authority (NRA) to provide a summary of the progress made on their regulatory projects as well as their priorities for 2021. Each NRA will have approximately 15-20 minutes to provide an update on progress made on several local, regional, and global projects as well as their priorities for the year that affect regulators and manufacturers/regulated sector in Latin America. A Q&A panel discussion will be held at the end of this session to provide any clarification where necessary.
Learning Objective : Upon completion of this session, the participant should be able to:
- Understand the progress made by NRAs in their projects
- Identify NRAs priorities for 2021
- Understand the impact of projects and priorities for regulators and manufacturers
Speaker(s)
Giorgos Iliou
Acting National Director of Health Surveillance, DINAVISA, Paraguay
Speaker
Susan Zavala Coloma, MS, RPH
Specialist, Sanitary Evaluation of Pharmaceutical Products, Biological Products , DIGEMID, Peru
Speaker
Rian Marie Extavour, PHD, MSC, RPH
Programme Manager, Caribbean Regulatory System, Caribbean Public Health Agency (CARPHA), Trinidad And Tobago
Speaker
Nicole Ennis, MSC
Head Medicines Quality Control and Surveillance Department, Caribbean Public Health Agency, Jamaica
Speaker
Gustavo Mendes Lima Santos, MPHARM
Herbal and Complementary Medicines Office - GMESP, Brazilian Health Regulatory Agency (ANVISA), Brazil
Speaker
Have an account?